Pancreatic steatosis-a new modifiable high-risk factor for post-ERCP pancreatitis: yet much to explore

Gastrointest Endosc. 2024 Sep;100(3):579-580. doi: 10.1016/j.gie.2024.03.037.
No abstract available

Publication types

  • Editorial
  • Letter

MeSH terms

  • Cholangiopancreatography, Endoscopic Retrograde* / adverse effects
  • Humans
  • Pancreas
  • Pancreatitis* / epidemiology
  • Pancreatitis* / etiology
  • Pancreatitis* / prevention & control
  • Risk Factors